alder Wyss successfully represented Grünenthal Pharma AG before the Swiss Federal Supreme Court. Both the order by the Federal Office of Public Health regarding the price...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Grünenthal on the offering. Grünenthal GmbH announced the pricing of €300 million aggregate principal amount of 6.75% senior secured notes due 2030. The...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Grünenthal Pharma GmbH & Co. KG. The €500 million financing is provided by an international banking syndicate and the transaction provides for an upsize...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Grünenthal. Allen & Overy advised Kyowa Kirin International. Grünenthal, the Germany-based global leader in pain management and related diseases, on a collaboration...
You must be a Standard 1 Year member to access this content.
Allen & Overy advised Bayer AG on the deal. Freshfields Bruckhaus Deringer advised Grünenthal. Bayer AG sold its men’s health product Nebido™ (testosterone undecanoate) to Grünenthal...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised Grünenthal GmbH on the offering. Grünenthal GmbH executed the offering of a bond in two tranches with a total volume of...
You must be a Standard 1 Year member to access this content.
Homburger advised Grünenthal GmbH on this matter, while Vischer advised the sellers of Mestex AG, supported by Orrick, Herrington & Sutcliffe. Grünenthal GmbH announced the acquisition...
You must be a Standard 1 Year member to access this content.
